Cargando…
Identification of Genes Associated with Liver Metastasis in Pancreatic Cancer Reveals PCSK6 as a Crucial Mediator
SIMPLE SUMMARY: Liver metastasis is the most frequent event of tumor progression in pancreatic cancer, and available therapeutics have achieved unsatisfactory outcomes. The underlying molecular mechanisms of liver metastasis in pancreatic cancer remain unclear and critical genes participating in thi...
Autores principales: | He, Hang, Zhang, Shuman, Yang, Hai, Xu, Pengyan, Kutschick, Isabella, Pfeffer, Susanne, Britzen-Laurent, Nathalie, Grützmann, Robert, Fu, Deliang, Pilarsky, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818395/ https://www.ncbi.nlm.nih.gov/pubmed/36612240 http://dx.doi.org/10.3390/cancers15010241 |
Ejemplares similares
-
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
por: Yang, Hai, et al.
Publicado: (2022) -
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2022) -
Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023) -
CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
por: Zeng, Siyuan, et al.
Publicado: (2022) -
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)